drugset / Trial / NCT03724227

Expanded Access for ACE-011

NCT03724227

Expanded access No longer available Celgene Corporation

Summary

This is an expanded access program (EAP) for eligible participants designed to provide access to ACE-011.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Sotatercept Protein / enzyme biologic Subcutaneous